MLM Biologics, Inc. is awarded almost $1.5 million by the U.S. Army Medical Research and Development Command (USAMRDC) to develop a device to prevent infection in battlefield wounds
Read MoreMLM Biologics recognized for sending humanitarian supplies to Puerto Roco after hurricane Maria
Read MoreClinical use of bio-ConneKt® Wound Matrix is presented at the Symposium for Advanced Wound Care
Read MoreMLM Biologics receives ISO 13485 Certification, and bio-ConneKt® Wound Matrix gets unique HCPCS Level II Q-code from the Centers for Medicare and Medicaid Services for reimbursement
Read MoreMLM Biologics receives 510(k) clearance from the US FDA for bio-ConneKt® Wound Matrix and completes its first product application
Read More